INDO-NATIONAL LTD.

Indo National Ltd has announced its 53rd Annual General Meeting (AGM) to be held on September 28, 2026. The company's Board of Directors, in a meeting on August 14, 2026, approved the unaudited standalone and consolidated financial statements for the quarter ended June 30, 2026. The results show a net loss of ₹228.97 Lakhs for the quarter, a significant improvement from the previous year's loss. The company also reported total income from operations of ₹11,584.57 Lakhs. The AGM intimation, book closure, and record date details are provided separately. The financial statements were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors.

Indo National Ltd announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a total income of ₹11674.76 lakhs and total expenses of ₹11968.79 lakhs, resulting in a net loss of ₹294.03 lakhs for the period. The Board of Directors also approved the unaudited financial statements and intimated that the 53rd AGM will be held on September 28, 2026, with book closure and record dates to be announced. The company's registered office is in Chennai, and its CIN is L31909TN1972PLC006196.

Indo National Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a net loss of ₹228.97 Lakhs for the period, a significant change from a profit of ₹106.80 Lakhs in the same quarter last year. Total income from operations for the quarter stood at ₹11,584.57 Lakhs, while total expenses were ₹11,968.79 Lakhs. The company also announced the 53rd AGM will be held on September 28, 2026, and has provided details for book closure and record date. The financial statements were reviewed by the Audit Committee and approved by the Board of Directors.

Indo National Ltd announced the outcome of its Board Meeting held on August 14, 2026. The board approved the unaudited standalone and consolidated financial statements for the quarter ended June 30, 2026. The company also intimated that its 53rd Annual General Meeting (AGM) will be held on September 28, 2026, with a book closure and record date to be announced. The financial statements were reviewed by the Audit Committee and received a limited review from statutory auditors M/s. G Balu & Associates LLP. The amalgamation of Helios Strategic Systems Limited with the company, effective from April 2, 2026, has been accounted for, and prior period figures have been restated.

Indo National Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026. The results will be both standalone and consolidated. The company will publish these results in newspapers post-approval. Additionally, the trading window for company insiders will remain closed from July 1, 2026, until 48 hours after the results declaration, in line with SEBI regulations.

Indo National Limited has invested ₹34,99,92,034 in Aidin Technologies Private Limited, acquiring 31.82% of its paid-up share capital. This investment includes 9,920 Series A CCPS and 12,202 Series A1 CCPS. Aidin Technologies specializes in radio frequency power electronics for defence, communications, and satellite technology, with a turnover of ₹71.51 Cr for FY24-25. The acquisition aims to establish Indo National Limited as a growth engine in the sunrise Defence & Aerospace sector, leveraging India's self-sufficiency plans. The investment is expected to boost revenue and profitability, balancing the company's business portfolio. Tranche 1 of the investment was completed on July 29, 2026, with Tranche 2 anticipated by July 28, 2027. The transaction is a cash consideration and is not a related party transaction.

Indo National Ltd has announced an additional investment of ₹49,93,872 in Medcuore Medical Solutions Private Limited (MMSPL) through the subscription of equity shares. This investment increases Indo National's stake in MMSPL by 0.75%, bringing its total shareholding to 61.09%. MMSPL is involved in the manufacturing and distribution of Air Monitoring Systems and Air Purifiers. The company stated the investment aims to facilitate business growth, generate revenue, and earn profits through business expansion. The acquisition is not a related party transaction, and no promoter group entities have an interest in MMSPL. The acquisition is expected to be completed by FY 2027-28.

Indo National Ltd has announced a further investment of ₹74,90,808 in Medcuore Medical Solutions Private Limited (MMSPL) through the subscription of equity shares. This investment represents an additional 1.18% stake, increasing Indo National's total shareholding in MMSPL to 60.34%. MMSPL is engaged in the manufacturing and distribution of Air Monitoring Systems and Air Purifiers. The company stated the investment aims to facilitate business growth, generate revenue, and earn profits through business expansion. The acquisition is not a related party transaction and is expected to be completed by FY 2027-28.

Indo National Ltd has announced the closure of its trading window for all designated persons, including promoters, directors, key managerial personnel, employees, insiders, connected persons, and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the company's unaudited first quarter results for the period ending June 30, 2026. During this period, these individuals are prohibited from trading in the company's securities. The trading window will reopen 48 hours after the announcement of the financial results.

Indo National Ltd has invested an additional ₹99.88 lakh in Medcuore Medical Solutions Private Ltd (MMSPL) by subscribing to equity shares. This investment represents an additional 1.68% of MMSPL's paid-up share capital on a fully diluted basis, increasing Indo National's aggregate shareholding to 59.16%. The acquisition does not fall under related party transactions. MMSPL's turnover for FY 25-26 was ₹1,45,60,000. The object of the acquisition is to facilitate business growth and generate revenue.